Glenmark Pharmaceuticals Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Total Qtr Revenue cr | 3,945.08 | 6,247.50 | 3,290.88 | 3,267.89 | 3,418.68 |
| Other Income Qtr Cr | 44.46 | 200.63 | 26.44 | 11.68 | 31.13 |
| Operating Revenues Qtr | 3,900.62 | 6,046.87 | 3,264.44 | 3,256.21 | 3,387.55 |
Loading chart... | |||||
Operating Expenses Qtr | 3,030.87 | 3,687.32 | 2,683.92 | 2,695.18 | 2,787.32 |
Operating Profit Qtr | 869.75 | 2,359.55 | 580.52 | 561.02 | 600.23 |
EBITDA Qtr Cr | 729.88 | 1,175.06 | 283.73 | 199.89 | 631.36 |
Depreciation Qtr | 154.45 | 141.20 | 129.93 | 125.20 | 122.74 |
Net Profit Qtr | 403.21 | 610.35 | 46.87 | 4.65 | 347.96 |
Basic EPS Qtr | 14.29 | 21.63 | 1.66 | 0.16 | 12.33 |
Open Demat Account